Literature DB >> 10445341

Paediatric Castleman disease: report of seven cases and review of the literature.

N Parez1, B Bader-Meunier, C C Roy, J P Dommergues.   

Abstract

UNLABELLED: Castleman disease is a distinct lymphoproliferative disorder of unknown origin. Seven new cases in children are reported here and 76 cases from the paediatric literature are reviewed. The disease has been reported in 46 females and 37 males, their age ranging from 2 months to 17 years. The disease was localized in 72 cases and multicentric in 11 cases. The hyalinovascular type was more frequently encountered (54%) than the plasma cell type (24%). Laboratory abnormalities were more often associated with the plasma cell type and were mainly represented by anaemia and hypergammaglobulinaemia. Treatment of the localized tumour consisted of surgical excision, whereas treatment of the multicentric form was medical, comprising prednisone and other immunosuppressor drugs. The disease in the paediatric population seems to have a more favourable course than in adults.
CONCLUSION: The paediatric features of the disease suggest that Castleman disease in this population could represent an earlier form of the pathology or even suggest a benign lymphoproliferative disorder.

Entities:  

Mesh:

Year:  1999        PMID: 10445341     DOI: 10.1007/s004310051166

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  Castleman's disease imitating adrenal mass in the retroperitoneal area.

Authors:  Gökhan Koç; Hakan Turk; Sıtkı Un; Cemal Selcuk Isoglu; Ferruh Zorlu
Journal:  Can Urol Assoc J       Date:  2015 Jan-Feb       Impact factor: 1.862

2.  [A palpable right lower abdominal mass].

Authors:  C Paasch; E Gatzky; F Renger; M Steinbach; M Strik
Journal:  Chirurg       Date:  2017-07       Impact factor: 0.955

Review 3.  Multicentric Castleman disease in an HHV8-infected child born to consanguineous parents with systematic review.

Authors:  Sandrine Leroy; Despina Moshous; Olivier Cassar; Yves Reguerre; Minji Byun; Vincent Pedergnana; Danielle Canioni; Antoine Gessain; Eric Oksenhendler; Claire Fieschi; Nizar Mahlaoui; Jean-Pierre Rivière; Rose-Marie Herbigneaux; Matthias Muszlak; Jean-Pierre Arnaud; Alain Fischer; Capucine Picard; Stéphane Blanche; Sabine Plancoulaine; Jean-Laurent Casanova
Journal:  Pediatrics       Date:  2011-12-12       Impact factor: 7.124

4.  Surgical management of abdominal and retroperitoneal Castleman's disease.

Authors:  Pascal Bucher; Gilles Chassot; Guillaume Zufferey; Frederic Ris; Olivier Huber; Philippe Morel
Journal:  World J Surg Oncol       Date:  2005-06-07       Impact factor: 2.754

5.  Anemia resolved by thoracoscopic resection of a mediastinal mass: a case report of unicentric Castleman's disease.

Authors:  Jong Hui Suh; Sook Hee Hong; Seong Cheol Jeong; Chan Beom Park; Kuk Bin Choi; Ok Ran Shin; Si Young Choi
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

6.  Atypical presentation of multicentric Castleman disease in a pediatric patient: pleural and pericardial effusion.

Authors:  Alkim Oden Akman; Ozge Basaran; Derya Ozyoruk; Unsal Han; Tulin Sayli; Nilgun Cakar
Journal:  Eur J Pediatr       Date:  2015-11-27       Impact factor: 3.183

7.  Multicentric Castleman's disease in a child with subpectoral involvement.

Authors:  Polat Koşucu; Ali Ahmetoğlu; Mustafa Imamoğlu; Ali Cay; Umit Cobanoğlu; Halit Reşit Gümele
Journal:  Pediatr Radiol       Date:  2003-05-27

8.  Histologic and Laboratory Characteristics of Symptomatic and Asymptomatic Castleman Disease in the Pediatric Population.

Authors:  Karen M Chisholm; Mark D Fleming
Journal:  Am J Clin Pathol       Date:  2020-05-05       Impact factor: 2.493

Review 9.  Treatment of Castleman's disease.

Authors:  Angela Dispenzieri; Morie A Gertz
Journal:  Curr Treat Options Oncol       Date:  2005-05

Review 10.  Multicentric Castleman's disease in two cases.

Authors:  Rajni Sharma; Rachna Seth; V Thavaraj; A Bagga; S K Kabra; A K Karak; S Atri
Journal:  Indian J Pediatr       Date:  2007-12       Impact factor: 5.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.